ARYTX | MGLIX | ARYTX / MGLIX | |
Total Expense Ratio | 2.12 | 0.94 | 226% |
Annual Report Gross Expense Ratio | 2.12 | 0.95 | 223% |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 1.793 | -0.187 | -958% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 848M | 2.23B | 38% |
Annual Yield % from dividends | 1.10 | 2.60 | 42% |
Returns for 1 year | 8.91 | 0.29 | 3,121% |
Returns for 3 years | 7.54 | -8.44 | -89% |
Returns for 5 years | 29.98 | 20.96 | 143% |
Returns for 10 years | 29.95 | 23.99 | 125% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCHX | 12.77 | N/A | N/A |
Fidelity Select Chemicals | |||
FGEAX | 25.23 | N/A | N/A |
Fidelity Advisor Glbl Capital Apprec A | |||
JACJX | 18.53 | N/A | N/A |
JHancock Mid Cap Growth A | |||
JFNNX | 63.95 | -1.31 | -2.01% |
Janus Henderson Global Life Sciences N | |||
GQSCX | 12.62 | -0.37 | -2.85% |
Glenmede Disciplined US Small Cap Eq Ptf |